Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Update: Severe Acute Respiratory Syndrome --- United States, June
18, 2003
CDC continues to work with state and local health departments, the World Health Organization (WHO), and
other partners to investigate cases of severe acute respiratory syndrome (SARS). This report updates reported SARS cases worldwide and in the United States and summarizes changes in travel recommendations for provinces in China with the exclusion of Beijing, where a travel advisory remains.
During November 1, 2002--June 18, 2003, a total of 8,465 probable SARS cases were reported to WHO from 29
countries, including 75 from the United States; 801 deaths (case-fatality proportion: 9.5%) have been reported, with no SARS-related deaths reported from the United States
(1). In the United States, a total of 409 SARS cases have been
reported from 42 states and Puerto Rico, with 334 (82%) cases classified as suspect SARS and 75 (18%) classified as probable SARS (i.e., more
severe illnesses characterized by the presence of pneumonia or acute respiratory distress syndrome)
(2). Serologic testing for antibody to SARS-associated coronavirus (SARS-CoV) infection has been completed for 136 suspect and 45 probable cases. None of the suspect cases and eight (18%) of the probable cases have demonstrated
antibodies to SARS-CoV, all of which have been described previously
(3,4). Of the eight laboratory-confirmed SARS
patients in the United States, seven had traveled to
areas with documented or suspected community transmission of SARS within the 10 days before illness onset. Of these,
four reported travel to Hong Kong Special Administrative Region, China; two to Toronto, Canada; and one to both Singapore and Taiwan. The remaining laboratory-confirmed SARS patient is the spouse of a laboratory-confirmed SARS patient that
had traveled to Hong Kong.
On June 17, CDC downgraded its travel advisory for Mainland China to alert status for all provinces except Beijing,
where the travel advisory remains in effect
(5). These changes reflect data reported to the World Health Organization by
the Chinese Ministry of Health which indicate that SARS transmission in Mainland China (other than in Beijing) is limited to
a small number of specific settings through direct person-to-person spread; no evidence exists of ongoing
community transmission, and monitoring by the Ministry of Health indicates that no new outbreaks of illness in these provinces.
Reported by: State and local health departments. SARS Investigative Team, CDC.
CDC. Interim travel alert: Mainland China (excluding Beijing). Available at
http://www.cdc.gov/travel/other/sarschina2.htm.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
